2152-2650
Bimonthly
No
CL LYMPH MYELOM LEUK
2010
148
UNITED STATES
http://www.journals.elsevier.com/clinical-lymphoma-myeloma-and-leukemia
较慢,6-12周审稿时间
较易平均录用比例
2.7影响因子
血液学小学科
37/98JIF RANK
4175总被引频次
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
《临床淋巴瘤、骨髓瘤和白血病》是一本同行评议的月刊,发表了描述淋巴瘤、骨髓瘤和白血病临床和转化研究各个方面的原始文章。《临床淋巴瘤、骨髓瘤和白血病》专门研究淋巴瘤、骨髓瘤、白血病和相关疾病的检测、诊断、预防和治疗,包括巨球蛋白血症、淀粉样变性和浆细胞贫血。重点是淋巴瘤、骨髓瘤和白血病相关领域的最新科学进展。感兴趣的特定领域包括临床研究和机械方法;药物敏感性和耐药性;基因和反义疗法;病理学、标记物和预后指标;化学预防策略;多模式疗法;以及各种方法的整合。
http://ees.elsevier.com/clml/
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.